Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Portland, Oregon 25 trials found
New Search
Filter
Trial Phase
Study Type
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
PHASE2INTERVENTIONAL Tampa, Florida +4 more
RECRUITING
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
PHASE1INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
N/AOBSERVATIONAL Duarte, California +4 more
RECRUITING
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Identifying and Caring for Individuals With Inherited Cancer Syndrome
NAINTERVENTIONAL Portland, Oregon +1 more
RECRUITING
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
PHASE2INTERVENTIONAL Portland, Oregon
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Connect for Cancer Prevention Study (Connect)
N/AOBSERVATIONAL Denver, Colorado +4 more
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
PHASE2, PHASE3INTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Precision-Based Genomics in Prostate Cancer
N/AOBSERVATIONAL La Jolla, California +4 more
RECRUITING
Beat Childhood Cancer Specimen Banking and Data Registry
N/AOBSERVATIONAL Little Rock, Arkansas +4 more
RECRUITING
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NAINTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Clovis, California +4 more
RECRUITING
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type